WO2009009956A1 - A preparation method of sugar alcohol - Google Patents

A preparation method of sugar alcohol Download PDF

Info

Publication number
WO2009009956A1
WO2009009956A1 PCT/CN2008/001312 CN2008001312W WO2009009956A1 WO 2009009956 A1 WO2009009956 A1 WO 2009009956A1 CN 2008001312 W CN2008001312 W CN 2008001312W WO 2009009956 A1 WO2009009956 A1 WO 2009009956A1
Authority
WO
WIPO (PCT)
Prior art keywords
sugar
gene
genetically engineered
enzyme
reductase
Prior art date
Application number
PCT/CN2008/001312
Other languages
French (fr)
Chinese (zh)
Inventor
Jirong Liu
Yunfa Chi
Original Assignee
Beijing Great-Genius Science & Technology Development Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Great-Genius Science & Technology Development Company filed Critical Beijing Great-Genius Science & Technology Development Company
Publication of WO2009009956A1 publication Critical patent/WO2009009956A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals

Definitions

  • the invention belongs to the field of molecular biology, and discloses a method for preparing a sugar alcohol, which has the characteristics of low energy consumption and no pollution to the environment as compared with the conventional method.
  • the sugar alcohol produced by the present invention can be used in food, beverage and the like industries. Background technique
  • a method for producing sugar alcohols is usually to convert sugar into sugar alcohol by a hydrogenation reduction reaction using a catalyst, for example, a plant having a higher xylose content, such as corn cob, is degraded by dilute acid digestion, and the wood is separated from the degradation product. The sugar is then subjected to a hydrogenation reduction process to produce xylitol.
  • a catalyst for example, a plant having a higher xylose content, such as corn cob
  • the object of the invention is to enable microorganisms to convert sugar into sugar alcohols by homologous recombination of genes, thereby providing a low energy consumption and low pollution preparation method of sugar alcohols.
  • the present invention first provides a genetically engineered bacteria which utilizes a homologous recombination method to convert a sugar reductase and its corresponding sugar isomerase, phosphoglucose hydrolase, glycotopic enzyme and hydrogen to hydrogen.
  • the coding gene of the enzyme is integrated into the chromosome of the host, and the corresponding xylulose kinase of the host is inactivated during the integration process, so that the obtained transformant can convert the corresponding sugar into a corresponding sugar metabolism pathway provided by genetic recombination.
  • Sugar alcohol is a homologous recombination method to convert a sugar reductase and its corresponding sugar isomerase, phosphoglucose hydrolase, glycotopic enzyme and hydrogen to hydrogen.
  • the above hosts include bacteria, fungi, actinomycetes, animal and plant cells, etc.
  • bacteria are generally considered to be preferred hosts.
  • the host for the production of sugar alcohols is Corynebacterium glutamicum, which is currently widely used for the production of MSG.
  • the genetically engineered bacteria provided by the above method may be a genetically engineered bacteria that converts glucose into xylitol, and the inserted inactivated gene may be a xylose kinase gene, and the specific method is to The sequence flanking the glycan kinase gene and the xylose reductase gene, the xylose isomerase gene, the xylose hydrolase gene, the xylulose epitope enzyme gene, and the transhydrogenase gene are linked to each other, and the xylose kinase gene is flanked by The sequences are located at the 5' and 3' ends, respectively, and are integrated into the locus of the host xylulose kinase gene by homologous recombination and inactivate the gene.
  • the preferred xylose reductase is derived from Neurospora
  • the xylose isomerase, the xylulose hydrolase, and the transhydrogenase are all derived from Escherichia coli
  • the xylose phosphate epitope enzyme is derived from glutamine. Corynebacterium acidophilus.
  • each enzyme can carry its own promoter and ribosome binding sites, and all enzymes can share a promoter sequence.
  • one promoter common to all enzymes may be an promoter of Corynebacterium glutamicum xylulose kinase or a promoter of Corynebacterium glutamicum lactate dehydrogenase.
  • the present invention provides a method for producing a sugar alcohol which is obtained by converting the sugar into a sugar alcohol using the above genetically engineered bacteria.
  • the fermentation can be carried out by an immobilization method well known to those skilled in the art.
  • the present invention provides a preferred fermentation method, which is a mixture of sodium alginate solution and bacteria to prepare a mixture of sodium alginate at a final concentration of 1.8 to 2.2% and a bacterial content of about 10 9 pfo/ml.
  • the needle tube is dropped into a 5% CaCl 2 solution and immobilized for 25-30 minutes; the particles are filtered out, washed with physiological saline, and the washed particles are loaded into an immobilization column, and under the action of a peristaltic pump, 0.5 M glucose was added from the bottom of the column at a column volume of 0.1 column volume per minute, and the reaction liquid flowing out from the top of the column was circulated to ensure that it could react with the genetically engineered bacteria in the immobilized column for 2 hours. Then, the reaction liquid was collected, separated by a fluidized bed, and crystallized to obtain a sugar alcohol.
  • the term "genetically engineered bacteria” refers to bacteria, fungi, actinomycetes, and plant and animal cells which have been genetically engineered.
  • phosphohydrolase means an enzyme having the activity of hydrolyzing a phosphate group, such as “phosphonuosone hydrolase” means an enzyme having a hydrolysis activity of xylulose phosphate;
  • transhydrogenase refers to a protease that can convert NADH and NADPH to each other.
  • detailed description The following examples are intended to further illustrate the invention, but are not to be construed as limiting the invention. Modifications or substitutions of the methods, steps or conditions of the invention are intended to be within the scope of the invention.
  • the technical means used in the examples are conventional means well known to those skilled in the art unless otherwise specified.
  • the percentage (%) involved, unless otherwise specified, the percentage between liquids is a volume percentage
  • the percentage between solids is a weight percentage
  • the percentage between solid and liquid is a weight to volume ratio (10%) That is, it means that 10 g of solids per 100 ml of liquid is contained.
  • the hexose monophosphate pathway is the primary pathway for providing cells with a reducing oxygen donor NADPH and the five carbon sugars required for cell replication. It is also the main pathway in the cell for converting 6 carbon sugars such as glucose into 5 carbon sugars, 4 carbon sugars and 7 carbon sugars.
  • Xylitol is a product mainly used for human consumption. Therefore, the use of microorganisms for biotransformation requires the use of strains that are harmless or less harmful to humans.
  • Corynebacterium glutamicum is mainly used for the production of MSG and is widely considered to be a safe strain. Compared with other bacteria, Corynebacterium glutamicum has a characteristic that the hexose monophosphate pathway is highly active in the stationary phase of cell growth, and is particularly suitable for biotransformation using the active enzyme contained therein after immobilizing the bacteria. Through the metabolism study of Corynebacterium glutamicum, it is found that the lactate dehydrogenase promoter has high activity in the stationary phase of bacterial growth. Therefore, it is more suitable to place the relevant genes under the control of the promoter. Biotransformation of glucose.
  • NADPH is required as a cofactor and is completed by xylose reductase.
  • Phosphoryl xylulose hydrolase and xylose isomerase are required for glucose to become xylose.
  • Corynebacterium glutamicum The gene sequences of all Escherichia coli and Corynebacterium glutamicum in the examples are from the genome-wide sequence listed on the website of www.tigr.org. Escherichia coli is K12-MG1655, site number is 168927; Corynebacterium glutamicum is ATCC13032 Bielfeld, site number is 196627, and GeneBank of R. sphaeroides xylose reductase is serial number AY876382.
  • the following primers were designed to amplify the upstream and downstream sequences of the gene, and then the upstream and downstream sequences were ligated into a fragment by overlapping PCR.
  • ⁇ ⁇ , Pstl, Nsil, Hindlll, Bspel, Xhol, Kpnl, EcoRl, Nhel, ApaLl and Xmal restriction sites were inserted in the middle of the two for sequential cloning.
  • Corynebacterium glutamicum was grown overnight in LB (1% protein, 0.5% yeast powder, 0.5% NaCi, pH 7.5), and the precipitate was collected by centrifugation.
  • the reaction was carried out at ° C for 30 minutes.
  • Reaction procedure 94 ° C for 2 minutes; then 94 ° C for 30 seconds, 55 ° C for 30 seconds, 72 ° C for 1 minute, cycle 35 times; finally 72 ° C for 10 minutes.
  • Step 1.3.2 The upstream fragment obtained 3.0 ⁇
  • Step 1.3.2 The resulting downstream fragment 3.0 ⁇
  • Reaction procedure 94 ° C for 2 minutes; then 94 ° C for 30 seconds, 55 ° C for 30 seconds, 72 ° C for 1 minute and 30 seconds, cycle 35 times; finally 72 ° C extension for 10 minutes.
  • the obtained PCR fragment was digested with Noil, and after electrophoresis on 1.2% agarose, it was recovered from the gel for use.
  • PSZTC2000 was digested with enzyme and treated with calf intestinal alkaline phosphatase, and the fragment was recovered. And connected with the fragment obtained in step 1.4, precipitated by adding yeast tRNA, 3M sodium acetate and absolute ethanol, rinsed with 70% ethanol, electrolyzed into E. coli, cultured on LB/ampicillin medium at 37 °C. overnight. A single colony was picked and grown overnight in a liquid of LB/ampicillin. The corresponding plasmid was prepared and digested by NWI. The fragment of 1 177 bp was released, and the desired plasmid was designated as pSZTC 2001 after being correctly sequenced. Cloning of the original enzyme gene:
  • the reaction was carried out at 42 ° C for 2 hours.
  • Step 2.3 cDNA 1.0 ⁇ ⁇ 2.5 ⁇ / ⁇ 1 1.0 ⁇
  • Reaction procedure 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 1 minute, cycle 30 times; finally at 72 ° C for 10 minutes.
  • the obtained PCR fragment was digested with EcoRl, cloned into pUC 19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2002.
  • Gaattctccggacccgggcattccgctagcttaattcagcacatacttctcaatagcaacg (amplification product 813bp)
  • Reaction procedure 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 1 minute, cycle 30 times; finally at 72 ° C for 10 minutes.
  • the obtained PCR fragment was digested with EcoM, cloned into pUC 19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2003.
  • Reaction procedure 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 1 minute and 30 seconds, cycle 30 times; finally at 70 ° C for 10 minutes.
  • the obtained PCR fragment was digested with EcoR1, cloned into pUC19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2004.
  • Reaction procedure 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ⁇ 15 seconds, 72 ° C for 1 minute 30 seconds, cycle 30 times; finally at 72 ° C for 10 minutes.
  • the obtained PCR fragment was digested with Pst ⁇ , cloned into pUC 19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2005.
  • Reaction procedure 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 1 minute, cycle 30 times; finally at 72 ° C for 10 minutes.
  • pSZTC2006 The obtained PCR fragment was digested with EcoRl and cloned into the same digestion treatment.
  • pUC19 after sequencing confirmation, it was named pSZTC2006.
  • Reaction procedure 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 30 seconds, cycle 30 times; finally at 72 ° C for 10 minutes.
  • the obtained PCR fragment was digested with EcoRl, cloned into pUC19 treated with the same restriction enzyme, and confirmed by sequencing, and designated as pSZTC2007.
  • Reaction procedure 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 5 (TC 15 seconds, 72 ° C for 1 minute, cycle 30 times; finally extended at 72 ° C for 10 minutes.
  • the obtained PCR fragment was digested with ftrt, cloned into pUC19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2008.
  • pSZTC2001 was digested with N3 ⁇ 4I and ⁇ wl, and treated with calf intestinal alkaline phosphatase, and the fragment was recovered for use.
  • 9.2 pSZTC2002, pSZTC2003, pSZTC2004, pSZTC2005, pSZTC2006, pSZTC2007 and pSZTC2008 were digested with Xba ⁇ and BspEl, respectively, and 969 bp, 813 bp, 1323 bp, 1335 bp, 660 bp, 348 bp and 660 bp fragments were recovered from the agarose gel.
  • the fragment obtained by 9.1 was ligated with the 348 bp fragment obtained from pSZTC2007, electroporated into E. coli, and the obtained single plasmid was subjected to EcoRL. The 1525 bp fragment was released, and one of the desired plasmids was used.
  • Named pSZTC2009. .4 pSZTC2009 was digested with Nhel and Xmal and treated with calf intestinal alkaline phosphatase. The recovered fragment was ligated with the 969 bp fragment obtained from pSZTC2002, electroporated into E. coli, and the obtained single plasmid was used. £ RI digestion, where the 2494 bp fragment was released, one of the required plasmids was named pSZTC2010.
  • pSZTC2010 was digested with Mel and ⁇ , and the calf intestinal alkaline phosphatase was used.
  • the recovered fragment was ligated with the 813 bp fragment obtained from pSZTC2003, electroporated into E. coli, and the obtained single plasmid was digested with coRI, and the 3307 bp fragment was released, and the desired plasmid was used.
  • pSZTC201 1 was digested with N1 ⁇ 2I and wwl and treated with calf intestinal alkaline phosphatase. The recovered fragment was ligated with the 1323 bp fragment obtained from pSZTC2004, electroporated into E. coli, and the obtained single plasmid was treated with EcoRl. For those who released the 4630 bp fragment, one of the required plasmids was named pSZTC2012.
  • pSZTC2012 was digested with Nhel and Xmal, and treated with calf intestinal alkaline phosphatase.
  • the recovered fragment was ligated with the 660 bp fragment obtained from pSZTC2008, electroporated into E. coli, and EcoRl was used for the obtained single plasmid.
  • pSZTC2013 For those who released the 991 bp and 4109 bp fragments, one of the required plasmids, one of the required plasmids was named pSZTC2013.
  • pSZTC2013 was digested with Nhe ⁇ and Xm d and treated with calf intestinal alkaline phosphatase. The recovered fragment was ligated with the 660 bp fragment obtained from pSZTC2006, electroporated into E. coli, and the obtained single plasmid was used. EcoRl For the release of the 1651 bp and 4109 bp fragments, one of the required plasmids was named pSZTC2014.
  • pSZTC2014 was digested with Nhel and Xmai and treated with calf intestinal alkaline phosphatase. The recovered fragment was ligated with the 1335 bp fragment obtained from pSZTC2005, electroporated into E. coli, and the obtained single plasmid was released with JScoRl. For the 1143 bp, 1843 bp and 4109 bp fragments, one of the required plasmids was named pSZTC2015.
  • the pBSZTC2015 was digested with Nort, and a 7095 bp fragment was recovered to have a fragment amount of 5 ⁇ g. Then connect with T4 DNA ligase, add yeast tRNA, 3M The precipitate was recovered from sodium acetate and absolute ethanol at 70 ° /. The ethanol was rinsed twice and then electrolyzed to Corynebacterium glutamicum at 2500 volts and then regenerated on LB/agar medium containing 10 ⁇ g/liter chloramphenicol. The obtained chloramphenicol-resistant colonies were identified by using 1. 1. IF and 2. 1. 1R, 5. 1. IF and 5. 1. 1R two pairs of primers, and those having 969 bp and 1335 bp fragments were positive strains. A total of 20 positive strains were obtained, and 3 of them were picked and named as BSZTC2000-2.
  • 10.2 BSZTC2000-2002 was grown overnight in LB/chloramphenicol medium, and the precipitate was collected. After rinsing with 0.1M phosphate buffer, the sodium alginate solution was mixed with the bacteria to make the final concentration of sodium alginate 2%. The bacterial content is about 10 9 pfb/ml; the sodium alginate and the bacterial mixture are dropped into a 5% CaCl 2 solution by a needle tube, and fixed for 8 hours; the particles are filtered out, washed with physiological saline, and used. .
  • step 10.3 The granules obtained in step 10.2 were placed in an immobilization column, and 0.5 M glucose was added from the bottom of the column according to a volume of 0.1 volume per minute under the action of a peristaltic pump to circulate the reaction liquid flowing from the top of the column to ensure The bacteria in the immobilized column were reacted for 2 hours.
  • the reaction solution is then collected, separated by a fluidized bed, and crystallized to obtain xylitol. After high pressure liquid phase analysis, the conversion rates of glucose were 66.8, 68.3% and 70%, respectively.
  • BRIEF DESCRIPTION OF THE SEQUENCE LISTING SEQ ID N0.1 and 2 in the sequence listing are 1. l. IF XylUp and 1. 1.
  • IR XylDn nucleotide sequence; SEQ ID N0.3 and 4 are 1. 1.2FXylUp 1 and 1.
  • IF NCXRFXbal SEQ ID NO. 7 and 8 are respectively 1.
  • IF NCXRFXbal SEQ ID NO. 7 and 8 are respectively 1.5.
  • 1. IR NC XRR BspEI Xmal Nhel nucleotide sequence; SEQ ID NO. 9 and 10 are respectively 3. 1.
  • 11 and 12 are respectively 4. 1. IF EC XIFXbal and 4. 1. IR EC XIR BspEIXmalNhel nucleotide sequence; SEQ ID N0.13 and 14 are respectively 5. 1. IF EC TRAFXbal and 5. 1. IR EC Nucleotide sequence of TRAR BspEIXmalNhel; SEQ ID NO. 15 and 16 are respectively 6. 1. IF CGEP1FXbal and 6.1.1 RCGEPIBspEIXmalNhel nucleotide sequence; SEQ ID NO. 17 and 18 are respectively 7. 1. IF CGLDHPF Xbal And 1. 1. IR CGLDHPR BspEIXmalNhel nucleotide sequence; SEQ ID NO.
  • the invention provides a method for preparing a sugar alcohol, which utilizes a homologous recombination method to integrate a sugar reductase and its corresponding glycogen isomerase, phosphoglucose hydrolase, glycosylase and transhydrogenase encoding genes. On the chromosome of the host, the corresponding glycokinase of the host is inactivated during this integration process, so that the obtained transformant can convert the corresponding sugar into the corresponding sugar alcohol by utilizing the sugar metabolic pathway provided by genetic recombination.
  • the conversion rate of glucose to xylitol by the method of the present invention can reach 70% or more, indicating that the method of the present invention is expected to be used for large-scale industrial production.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A preparation method of sugar alcohol is provided, which comprises integrating sugar reductase and the corresponding isomerase, phosphonate hydrolyase, epimerase and transhydrogenase into the chromosome of the host through homologous recombination method, such that the xylulokinase of the host is inactivated and the transformant can convert sugars into corresponding sugar alcohols, using the sugar metabolic pathway provided by gene recombination.

Description

一种糖醇的制备方法  Method for preparing sugar alcohol
技术领域 Technical field
本发明属于分子生物学领域, 公开了一种糖醇的制备方法, 与传 统的方法相比, 具有能耗低, 不污染环境的特点。 利用本发明生产的 糖醇可以用于食品、 饮料等行业。 背景技术  The invention belongs to the field of molecular biology, and discloses a method for preparing a sugar alcohol, which has the characteristics of low energy consumption and no pollution to the environment as compared with the conventional method. The sugar alcohol produced by the present invention can be used in food, beverage and the like industries. Background technique
糖醇如山梨醇、 赤薛糖醇、 木糖醇等因其热量低、 代谢不受胰岛 素的限制, 并具有预防龋齿等功效, 广泛受到人们的关注。  Sugar alcohols such as sorbitol, erythritol, xylitol, etc., have been widely concerned because of their low calorie, metabolism and restriction of insulin, and the prevention of dental caries.
目前生产糖醇的方法,通常是利用催化剂通过加氢还原反应将糖 转化为糖醇,例如将木糖含量较高的植物秸轩如玉米芯经稀酸蒸煮降 解, 从降解产物中分离出木糖, 然后经过加氢还原工艺制得木糖醇。 利用这种方法生产糖醇具有能耗高、 污染环境等缺点。 发明内容  At present, a method for producing sugar alcohols is usually to convert sugar into sugar alcohol by a hydrogenation reduction reaction using a catalyst, for example, a plant having a higher xylose content, such as corn cob, is degraded by dilute acid digestion, and the wood is separated from the degradation product. The sugar is then subjected to a hydrogenation reduction process to produce xylitol. The production of sugar alcohol by this method has the disadvantages of high energy consumption and environmental pollution. Summary of the invention
发明的目的在于通过基因的同源重组,使得微生物能够将糖转化 成为糖醇, 进而提供一种低能耗、 低污染的糖醇制备方法。  The object of the invention is to enable microorganisms to convert sugar into sugar alcohols by homologous recombination of genes, thereby providing a low energy consumption and low pollution preparation method of sugar alcohols.
为了达到上述目的, 本发明首先提供了一种基因工程菌, 其利用 同源重组方法,将一种糖还原酶及其相应的糖异构酶、磷酸糖水解酶、 糖表位酶和转氢酶的编码基因整合到宿主的染色体上,在这一整合过 程中使宿主的相应木酮糖激酶失活,使所获得的转化子能够利用基因 重组提供的糖代谢通路将相应的糖转化成为相应的糖醇。  In order to achieve the above object, the present invention first provides a genetically engineered bacteria which utilizes a homologous recombination method to convert a sugar reductase and its corresponding sugar isomerase, phosphoglucose hydrolase, glycotopic enzyme and hydrogen to hydrogen. The coding gene of the enzyme is integrated into the chromosome of the host, and the corresponding xylulose kinase of the host is inactivated during the integration process, so that the obtained transformant can convert the corresponding sugar into a corresponding sugar metabolism pathway provided by genetic recombination. Sugar alcohol.
上述的宿主包括细菌、 真菌、 放线菌、 动植物细胞等, 在这些宿 主中, 动植物细胞的成本相对较高, 通常细菌被认为是优选的宿主。 在本发明实施中, 用于生产糖醇的宿主是谷氨酸棒状杆菌, 这中细菌 目前被广泛地用于味精的生产。  The above hosts include bacteria, fungi, actinomycetes, animal and plant cells, etc. Among these hosts, the cost of plant and animal cells is relatively high, and bacteria are generally considered to be preferred hosts. In the practice of the present invention, the host for the production of sugar alcohols is Corynebacterium glutamicum, which is currently widely used for the production of MSG.
按上述方法提供的基因工程菌,可以是将葡萄糖转化为木糖醇的 基因工程菌, 插入失活的基因可以是木糖激酶基因, 具体方法是将木 糖激酶基因两侧的序列以及木糖还原酶基因、 木糖异构酶基因、磷酸 木糖水解酶基因、 木酮糖表位酶基因和转氢酶基因相连接, 木糖激酶 基因两侧的序列分别位于 5'和 3'端,通过同源重组的方式,整合到宿 主木酮糖激酶基因所在的位置,并使该基因失活。在本发明实施例中, 优选的木糖还原酶来自粗糙链孢霉,木糖异构酶、磷酸木酮糖水解酶、 转氢酶均来自大肠杆菌, 磷酸木酮糖表位酶来自谷氨酸棒状杆菌。 The genetically engineered bacteria provided by the above method may be a genetically engineered bacteria that converts glucose into xylitol, and the inserted inactivated gene may be a xylose kinase gene, and the specific method is to The sequence flanking the glycan kinase gene and the xylose reductase gene, the xylose isomerase gene, the xylose hydrolase gene, the xylulose epitope enzyme gene, and the transhydrogenase gene are linked to each other, and the xylose kinase gene is flanked by The sequences are located at the 5' and 3' ends, respectively, and are integrated into the locus of the host xylulose kinase gene by homologous recombination and inactivate the gene. In an embodiment of the present invention, the preferred xylose reductase is derived from Neurospora, the xylose isomerase, the xylulose hydrolase, and the transhydrogenase are all derived from Escherichia coli, and the xylose phosphate epitope enzyme is derived from glutamine. Corynebacterium acidophilus.
如本领域技术人员所知,每一种酶都可以单独带有自己的促进子 和核糖体结合位点, 所有的酶也可以共用一个促进子序列。  As is known to those skilled in the art, each enzyme can carry its own promoter and ribosome binding sites, and all enzymes can share a promoter sequence.
对于用于制备木糖醇而言,所有的酶共用的一个促进子可以是谷 氨酸棒状杆菌木酮糖激酶的促进子,也可以是谷氨酸棒状杆菌乳酸脱 氢酶的促进子。  For the preparation of xylitol, one promoter common to all enzymes may be an promoter of Corynebacterium glutamicum xylulose kinase or a promoter of Corynebacterium glutamicum lactate dehydrogenase.
进一步, 本发明提供一种制备糖醇的方法, 其是利用上述基因工 程菌将糖转变为糖醇。可釆用本领域技术人员所熟知的固定化方法进 行发酵。 本发明提供了一种优选的发酵方法, 其是将海藻酸钠溶液与 菌体混合制成海藻酸钠终浓度为 1.8~2.2%、 含菌量约 109pfo/ml的混 合液, 然后用针形管滴入 5%的 CaCl2溶液中, 固定化 25-30分钟; 滤出颗粒, 用生理盐水洗净, 将洗净的颗粒装入固定化柱中, 并在蠕 动泵的作用下, 按照每分钟 0.1柱体积柱容从柱底加入 0.5M葡萄糖, 使从柱顶流出的反应液循环,确保能够与固定化柱中的基因工程菌反 应 2小时。 然后收集反应液, 经流化床分离, 结晶, 即制得糖醇。 Further, the present invention provides a method for producing a sugar alcohol which is obtained by converting the sugar into a sugar alcohol using the above genetically engineered bacteria. The fermentation can be carried out by an immobilization method well known to those skilled in the art. The present invention provides a preferred fermentation method, which is a mixture of sodium alginate solution and bacteria to prepare a mixture of sodium alginate at a final concentration of 1.8 to 2.2% and a bacterial content of about 10 9 pfo/ml. The needle tube is dropped into a 5% CaCl 2 solution and immobilized for 25-30 minutes; the particles are filtered out, washed with physiological saline, and the washed particles are loaded into an immobilization column, and under the action of a peristaltic pump, 0.5 M glucose was added from the bottom of the column at a column volume of 0.1 column volume per minute, and the reaction liquid flowing out from the top of the column was circulated to ensure that it could react with the genetically engineered bacteria in the immobilized column for 2 hours. Then, the reaction liquid was collected, separated by a fluidized bed, and crystallized to obtain a sugar alcohol.
在本发明中, 术语 "基因工程菌"是指经基因工程手段改造后的 细菌、 真菌、 放线菌以及动植物细胞。  In the present invention, the term "genetically engineered bacteria" refers to bacteria, fungi, actinomycetes, and plant and animal cells which have been genetically engineered.
术语 "磷酸糖水解酶"是指具有水解磷酸基团活性的酶, 如 "磷 酸木酮糖水解酶" 是指具有磷酸木酮糖水解活性的酶;  The term "phosphohydrolase" means an enzyme having the activity of hydrolyzing a phosphate group, such as "phosphonuosone hydrolase" means an enzyme having a hydrolysis activity of xylulose phosphate;
术语 "转氢酶" 是指可以使 NADH和 NADPH相互转化的蛋白 酶。 具体实施方式 以下实施例进一步说明本发明的内容,但不应理解为对本发明的 限制。 在不背离本发明精神和实质的情况下, 对本发明方法、 步骤或 条件所作的修改或替换, 均属于本发明的范围。 The term "transhydrogenase" refers to a protease that can convert NADH and NADPH to each other. detailed description The following examples are intended to further illustrate the invention, but are not to be construed as limiting the invention. Modifications or substitutions of the methods, steps or conditions of the invention are intended to be within the scope of the invention.
若未特别指明,实施例中所用的技术手段为本领域技术人员所熟 知的常规手段。 实施例中, 所涉及到的百分比(%), 若未特别指出, 液体之间的百分比为体积百分比, 固体之间的百分比为重量百分比, 固体与液体之间的百分比为重量体积比( 10%即表示每 100ml液体中 含固体 10g )。  The technical means used in the examples are conventional means well known to those skilled in the art unless otherwise specified. In the examples, the percentage (%) involved, unless otherwise specified, the percentage between liquids is a volume percentage, the percentage between solids is a weight percentage, and the percentage between solid and liquid is a weight to volume ratio (10%) That is, it means that 10 g of solids per 100 ml of liquid is contained.
己糖单磷酸通路是为细胞提供还原性氧供体 NADPH 和细胞复 制所需要的五碳糖的主要通路。 同时也是细胞内主要的使葡萄糖等 6 碳糖转化为 5碳糖、 4碳糖和 7碳糖的通路。  The hexose monophosphate pathway is the primary pathway for providing cells with a reducing oxygen donor NADPH and the five carbon sugars required for cell replication. It is also the main pathway in the cell for converting 6 carbon sugars such as glucose into 5 carbon sugars, 4 carbon sugars and 7 carbon sugars.
木糖醇为主要用于人体消费的产品, 因此, 利用微生物进行生物 转化, 必须使用对人体无害或危害较小的菌株。 谷氨酸棒状杆菌主要 用于味精的生产, 被广泛认为是安全的菌株。 与其它的细菌相比, 谷 氨酸棒状杆菌具有己糖单磷酸通路在细胞生长的静止期高活性的特 点, 特别适于将细菌固定化后, 利用其所含的活性酶进行生物转化。 通过对谷氨酸棒状杆菌的代谢研究发现,其乳酸脱氢酶促进子在细菌 生长的静止期具有很高的活性, 因此, 将相关的基因置于该促进子的 控制之下, 会更适合于葡萄糖的生物转化。  Xylitol is a product mainly used for human consumption. Therefore, the use of microorganisms for biotransformation requires the use of strains that are harmless or less harmful to humans. Corynebacterium glutamicum is mainly used for the production of MSG and is widely considered to be a safe strain. Compared with other bacteria, Corynebacterium glutamicum has a characteristic that the hexose monophosphate pathway is highly active in the stationary phase of cell growth, and is particularly suitable for biotransformation using the active enzyme contained therein after immobilizing the bacteria. Through the metabolism study of Corynebacterium glutamicum, it is found that the lactate dehydrogenase promoter has high activity in the stationary phase of bacterial growth. Therefore, it is more suitable to place the relevant genes under the control of the promoter. Biotransformation of glucose.
由木糖变为木糖醇, 需要以 NADPH为辅助因子, 由木糖还原酶 来完成。葡萄糖变为木糖需要磷酸木酮糖水解酶和木糖异构酶。同时, 需要将在体内将木酮糖变为磷酸木酮糖的木酮糖激酶灭活, 以消除体 内的无效耗能反应, 使更多的葡萄糖转变为木糖醇。  From xylose to xylitol, NADPH is required as a cofactor and is completed by xylose reductase. Phosphoryl xylulose hydrolase and xylose isomerase are required for glucose to become xylose. At the same time, it is necessary to inactivate xylulose kinase which converts xylulose into xylulose in vivo to eliminate inefficient energy-consuming reactions in the body and convert more glucose into xylitol.
从葡萄糖变为木糖醇需要消耗一分子的 NADPH, 而从葡萄糖变 为木糖, 细菌共产生 2 分子的 NADPH, 为了纠正这种不平衡, 需要 使用可以使 NADPH和 NADH相互转化的转氢酶。 这样可以使细胞 多余的还原能用于细胞的氧化反应, 供给细胞能量, 使更多的葡萄糖 转变为木糖醇。 From glucose to xylitol, one molecule of NADPH is consumed, and from glucose to xylose, the bacteria produce two molecules of NADPH. To correct this imbalance, a transhydrogenase that converts NADPH and NADH into each other is required. . This allows the excess reduction of cells to be used in the oxidation of cells, supplying cellular energy and making more glucose. Change to xylitol.
下面以谷氨酸棒状杆菌为例本发明的详细实施方法,实施例中所 有的大肠杆菌和谷氨酸棒状杆菌的基因序列均来自 www.tigr.org的网 站中所列的全基因组测定的序列, 大肠杆菌为 K12-MG1655 , 网站编 号为 168927; 谷氨酸棒状杆菌为 ATCC13032 Bielfeld, 网站编号为 196627, 粗糙链孢霉木糖还原酶的 GeneBank的序列号为 AY876382。  The following is a detailed implementation of the present invention by using Corynebacterium glutamicum as an example. The gene sequences of all Escherichia coli and Corynebacterium glutamicum in the examples are from the genome-wide sequence listed on the website of www.tigr.org. Escherichia coli is K12-MG1655, site number is 168927; Corynebacterium glutamicum is ATCC13032 Bielfeld, site number is 196627, and GeneBank of R. sphaeroides xylose reductase is serial number AY876382.
1.谷氨酸棒状杆菌木酮糖激酶基因同源序列的克隆: 1. Cloning of the homologous sequence of the xyloglucan kinase gene of Corynebacterium glutamicum:
1.1 根据谷氨酸棒状杆菌木酮糖激酶基因及其两侧的序列, 特设计 下列引物,用以扩增该基因的上游和下游序列,然后再通过重叠 PCR 将上下游序列连接成一条片段, 并在二者的中间插入 ν^ ΐ, Pstl, Nsil, Hindlll, Bspel, Xhol, Kpnl, EcoRl, Nhel, ApaLl 和 Xmal酶切位 点, 用于顺序克隆。  1.1 According to the Corynebacterium glutamicum xylulose kinase gene and its flanking sequences, the following primers were designed to amplify the upstream and downstream sequences of the gene, and then the upstream and downstream sequences were ligated into a fragment by overlapping PCR. ν^ ΐ, Pstl, Nsil, Hindlll, Bspel, Xhol, Kpnl, EcoRl, Nhel, ApaLl and Xmal restriction sites were inserted in the middle of the two for sequential cloning.
1.1. IF XylUp 5 ' gaatccgcggccgccaccatcggcgttgattacgcatt  1.1. IF XylUp 5 ' gaatccgcggccgccaccatcggcgttgattacgcatt
1.1.1R XylDn 5' aagcttatgcatggtaccgggcccgcggacaagcaaagccttgca  1.1.1R XylDn 5' aagcttatgcatggtaccgggcccgcggacaagcaaagccttgca
ggattg (扩增产物 534bp )  Ggattg (amplification product 534bp)
1.1.2 F Xy lUpl 1.1.2 F Xy lUpl
5' cgcgggcccctgcagatgcataagctttccggactcgagggtaccgaattcgctagcgtgc accccgggttcggccatgagattgtggttcca  5' cgcgggcccctgcagatgcataagctttccggactcgagggtaccgaattcgctagcgtgc accccgggttcggccatgagattgtggttcca
1.1.2R XylDnl gaatccgcggccgctgttcaatttggtgcgccctgatc ( 扩增产物 643bp ) 1.1.2R XylDnl gaatccgcggccgctgttcaatttggtgcccccctgatc (amplification product 643bp)
1.2 谷氨酸棒状杆菌染色体 DNA的制备:  1.2 Preparation of Corynebacterium glutamicum Chromosomes DNA:
1.2.1将过夜生长在 LB (1%蛋白陈, 0.5%酵母粉, 0.5%NaCi, pH7.5) 中的谷氨酸棒状杆菌, 经离心收集沉淀。  1.2.1 Corynebacterium glutamicum was grown overnight in LB (1% protein, 0.5% yeast powder, 0.5% NaCi, pH 7.5), and the precipitate was collected by centrifugation.
1.2.2将沉淀悬浮在 20%庶糖, 50mmol/L Tris-HCI (pH7.6)和 50mmol1.2.2 Suspension of the precipitate in 20% sucrose, 50 mmol/L Tris-HCI (pH 7.6) and 50 mmol
/L EDTA中, 然后加入溶菌酶使其终浓度为 8亳克 /毫开, 于 25/L EDTA, then add lysozyme to a final concentration of 8 g / m, at 25
°C反应 30分钟。 The reaction was carried out at ° C for 30 minutes.
1.2.3加入 10%SDS使其终浓度为 0.5%, 蛋白酶 K使其终浓度为 100 微克 /毫升, 于 37 °C反应 10分钟, 然后于 75°C再反应 5分钟。 1.2.4加入等体积的苯酚, 颠倒混匀十次, 于 3500转 /分离心 10分钟。 1.2.5取上清, 加入 1/2体积的苯酚 /氯仿 /异戊醇 (25: 24:1), 颠倒混匀 卡次, 于 3500转离心 10分钟。 1.2.3 Add 10% SDS to a final concentration of 0.5%, and proteinase K to a final concentration of 100 The microgram/ml was reacted at 37 ° C for 10 minutes and then further reacted at 75 ° C for 5 minutes. 1.2.4 Add an equal volume of phenol, mix it upside down ten times, and centrifuge at 3500 rpm for 10 minutes. 1.2.5 Take the supernatant, add 1/2 volume of phenol / chloroform / isoamyl alcohol (25: 24:1), mix and invert the card, and centrifuge at 3500 rpm for 10 minutes.
1.2.6取上清, 加入 1/2体积的氯仿 /异戊醇 (24: 1), 颠倒混匀十次, 于1.2.6 Take the supernatant, add 1/2 volume of chloroform / isoamyl alcohol (24: 1), mix it upside down ten times,
3500转离心 10分钟。 Centrifuge at 3500 rpm for 10 minutes.
1.2.7取上清,加入 2倍体积的无水乙醇,于 12000转 /离心 10分钟后, 弃上清, 力卩 入 70%的乙醇, 漂洗 2次。 弃上请, 经空气干燥。 1.2.8溶解于无菌水中, 使其浓度为 10纳克 /微升。 1.2.7 Take the supernatant, add 2 volumes of absolute ethanol, and after 12000 rpm / centrifugation for 10 minutes, discard the supernatant, force into 70% ethanol, and rinse twice. Discard, please dry with air. 1.2.8 Dissolve in sterile water to a concentration of 10 ng / microliter.
1.3 谷氨酸棒状杆菌木酮糖激酶基因上下游序列的 PCR (聚合酶链式 反应)扩增: 1.3 PCR (polymerase chain reaction) amplification of the upstream and downstream sequences of the xyloglucan kinase gene of Corynebacterium glutamicum:
1.3.1上游序列的扩增:  1.3.1 Amplification of the upstream sequence:
ΙΟ χ Ρήι缓冲液 5.0 μΐ  ΙΟ χ Ρήι buffer 5.0 μΐ
dNTP 2mM 5.0 μΐ  dNTP 2mM 5.0 μΐ
1.1.1Ρ 2μΜ 5.0 μΐ  1.1.1Ρ 2μΜ 5.0 μΐ
1 ·1 ·1Ι 2μΜ 5.0 μΐ  1 ·1 ·1Ι 2μΜ 5.0 μΐ
谷 1犬杆菌^ ^DNAIO纳 5.0 μΐ  Valley 1 Canine bacillus ^ ^DNAIO nano 5.0 μΐ
无菌水 24. 5 μ1  Sterile water 24. 5 μ1
Pfu (2.5 μ/μΐ) 0.5 μΐ  Pfu (2.5 μ/μΐ) 0.5 μΐ
和下游序列的扩增:  And amplification of downstream sequences:
lO x Pfu缓冲液 5.0 μΐ  lO x Pfu buffer 5.0 μΐ
dNTP 2mM 5.0 μΐ  dNTP 2mM 5.0 μΐ
1.1.2F 2μΜ 5.0 μΐ  1.1.2F 2μΜ 5.0 μΐ
1. Ι .2Ι 2μΜ 5.0 μΐ  1. Ι .2Ι 2μΜ 5.0 μΐ
谷氨酸棒状杆菌染色体 DNA 10纳克 /微升 5.0 μΐ  Corynebacterium glutamicum chromosome DNA 10 ng / microliter 5.0 μΐ
无菌水 24.5 μΐ  Sterile water 24.5 μΐ
Pfu (2.5 μ/μΐ) 0.5 μΐ  Pfu (2.5 μ/μΐ) 0.5 μΐ
反应程序: 94°C 2分钟; 然后 94°C 30秒, 55°C 30秒, 72 C 1 分钟, 循环 35次; 最后 72°C延伸 10分钟。  Reaction procedure: 94 ° C for 2 minutes; then 94 ° C for 30 seconds, 55 ° C for 30 seconds, 72 ° C for 1 minute, cycle 35 times; finally 72 ° C for 10 minutes.
1.3.2将 PCR产物在 1.2%琼脂糖胶上电泳,然后用杭州波日公司的胶 回收试剂盒回收上游和下游序列, 溶于 50微升无菌水中备用。 1.4 谷氨酸棒状杆菌木酮糖激酶基因上下游序列的重叠 PCR扩增: 建立下列反应体系: 1.3.2 The PCR product was electrophoresed on 1.2% agarose gel, and then the upstream and downstream sequences were recovered by the gel recovery kit of Hangzhou Bori Company, and dissolved in 50 μl of sterile water for use. 1.4 Overlapping PCR amplification of the upstream and downstream sequences of the Corynebacterium glutamicum xylulose kinase gene: The following reaction system was established:
lOxPfo缓冲液 5.0 μΐ  lOxPfo buffer 5.0 μΐ
dNTP 2mM 5.0 μΐ  dNTP 2mM 5.0 μΐ
1.1.ΙΡ2μΜ 5.0 μΐ  1.1.ΙΡ2μΜ 5.0 μΐ
1.1.2Κ2μΜ 5.0 μΐ  1.1.2Κ2μΜ 5.0 μΐ
步骤 1.3.2所得的上游片段 3.0 μΐ  Step 1.3.2 The upstream fragment obtained 3.0 μΐ
步骤 1.3.2所得的下游片段 3.0 μΐ  Step 1.3.2 The resulting downstream fragment 3.0 μΐ
无菌水 19.5μ1  Sterile water 19.5μ1
Pfu (2.5 μ/μΐ) 0.5 μΐ  Pfu (2.5 μ/μΐ) 0.5 μΐ
反应程序: 94°C 2分钟; 然后 94°C 30秒, 55°C 30秒, 72°C 1 分钟 30秒, 循环 35次; 最后 72°C延伸 10分钟。  Reaction procedure: 94 ° C for 2 minutes; then 94 ° C for 30 seconds, 55 ° C for 30 seconds, 72 ° C for 1 minute and 30 seconds, cycle 35 times; finally 72 ° C extension for 10 minutes.
所获得的 PCR片段用 Noil酶切, 并经 1.2%的琼脂糖电泳后, 从 胶上回收备用。  The obtained PCR fragment was digested with Noil, and after electrophoresis on 1.2% agarose, it was recovered from the gel for use.
1.5 克隆同源序列片段用质粒的构建:  1.5 Construction of cloned homologous sequence fragments using plasmids:
1.5.1人工合成下列序列:  1.5.1 Synthesize the following sequences:
1.5.1FBamHINotIEcoRI  1.5.1FBamHINotIEcoRI
ggaggattcgcggccgcgaattctcc Ggaggattcgcggccgcgaattctcc
1.5. lRBamHINotlEcoRI  1.5. lRBamHINotlEcoRI
ggagaattcgcggccgcggatcctcc Ggagaattcgcggccgcggatcctcc
1.5.2将 1.5. IF和 1.5. 1R片段各 2微克溶于 20微升无菌水中, 于 95°C变性 5 分钟, 然后缓慢冷却到 25°C, 加入 2.5微升的 10χ EcoRl缓冲液, 各加入 1微升 20单位 /微升的 Ecom和 BamHL 于 37°C反应 4小时。 然后加入 180微升的无菌水, 加入 50微升 的苯酚 /氯仿, 振荡混匀后, 于 12000转 /分离心 5分钟, 然后加 入 20微升 3M醋酸纳, pH5.2 , 加入 500微升的无水乙醇, 于 12000转 /分离心 15分钟, 弃上清。 加入 70%的乙醇漂洗 2次。 于空气中干燥后, 加入 20微升的无菌水备用。  1.5.2 Dissolve 1.5 μg of each of 1.5 IF and 1.5.1R in 20 μl of sterile water, denature at 95 ° C for 5 minutes, then slowly cool to 25 ° C, add 2.5 μl of 10 χ EcoRl buffer, One microliter of 20 units/microliter of Ecom and BamHL were each reacted at 37 ° C for 4 hours. Then add 180 μl of sterile water, add 50 μl of phenol/chloroform, mix by shaking, centrifuge at 12,000 rpm for 5 minutes, then add 20 μl of 3 M sodium acetate, pH 5.2, add 500 μl. The absolute ethanol was centrifuged at 12,000 rpm for 15 minutes and the supernatant was discarded. Rinse twice with 70% ethanol. After drying in air, add 20 μl of sterile water for use.
1. 5. 3向 10.0微升(1.0微克) pUC18中, 加入 4.0微升的 10x EcoRl 缓冲液, 24微升无菌水, 各加入 1微升 20单位 /微升的 EcoRl 和 B rniHl, 于 37°C反应 4 小时后, 加入 1微升 ( 1单位 /微升) 的小牛肠道碱性磷酸酶, 于 37°C反应 30分 钟。 然后加入 180 微升的无菌水,加入 50微升的苯酚 /氯仿,振荡混匀后,于 12000 转 /分离心 5分钟, 然后加入 20微升 3M醋酸钠, pH 5.2, 加入 500微升的无水乙醇, 于 12000转 /分离心 15分钟, 弃上清。 加 入 70%的乙醇漂洗 2次。 于空气中干燥后, 加入 20微升的无菌 水备用。 1. 5. 3 to 10.0 μl (1.0 μg) pUC18, add 4.0 μl of 10x EcoRl buffer, 24 μl of sterile water, add 1 μl of 20 units/μl of EcoRl each. After reacting with B rniHl for 4 hours at 37 ° C, 1 μl (1 unit / microliter) of calf intestinal alkaline phosphatase was added and reacted at 37 ° C for 30 minutes. Then add 180 μl of sterile water, add 50 μl of phenol/chloroform, mix by shaking, and centrifuge at 12,000 rpm for 5 minutes, then add 20 μl of 3 M sodium acetate, pH 5.2, and add 500 μl. Anhydrous ethanol was centrifuged at 12,000 rpm for 15 minutes, and the supernatant was discarded. Rinse twice with 70% ethanol. After drying in air, add 20 μl of sterile water for use.
4将步骤 1. 5. 2和 1. 5. 3所获得的片段各取 4微升, 然后加入 1 微升 ΙΟχ T4 DNA连接酶缓冲液, 1微升 T4 DNA连接酶, 于 22°C连接 1小时。 然后加入 5微升 (3毫克 /毫升)的酵母 tRNA, 和 5微升 3M醋酸纳, pH 5.2, 加入 500微升的无水乙醇, 于 12000转 /分离心 15分钟, 弃上清。 加入 70%的乙醇漂洗 2次。 于空气中干燥后, 加入 10微升的无菌水, 并将电转到大肠杆菌 中, 于 37°C的 LB/ 氨苄青霉素培养基上过夜生长。 4 Take 4 μl of each of the fragments obtained in steps 1.5.2 and 1.5.3, then add 1 μl of T4 DNA ligase buffer, 1 μl of T4 DNA ligase, and connect at 22 °C. 1 hour. Then, 5 μl (3 mg / ml) of yeast tRNA, and 5 μl of 3 M sodium acetate, pH 5.2, and 500 μl of absolute ethanol were added, and the core was centrifuged at 12,000 rpm for 15 minutes, and the supernatant was discarded. Rinse twice with 70% ethanol. After drying in air, 10 μl of sterile water was added, and the electrophoresis was transferred to E. coli and grown overnight on LB/ampicillin medium at 37 °C.
5质粒的鉴定. '挑取单个菌落, 在 LB/氨苄青霉素的液体中培养过 夜。 制备得到相应的质粒, 并用 7 III和 Noil酶切, 凡释放出 410bp片段者, 为所需要的质粒, 名为 pSZTC2000。 Identification of 5 plasmids. 'Pick a single colony and culture overnight in LB/ampicillin liquid. The corresponding plasmid was prepared and digested with 7 III and Noil, and the 410 bp fragment was released, and the desired plasmid was named pSZTC2000.
有同源序列质粒的构建:  Construction of plasmids with homologous sequences:
将 PSZTC2000用 酶切, 用小牛肠道碱性磷酸酶处理后, 回 收片断。 并与步 骤 1.4所获得的片段连接, 经加入酵母 tRNA, 3M醋酸纳和无水乙醇沉淀, 70% 的乙醇漂洗后, 电转到大肠杆 菌中, 于 37°C的 LB/氨苄青霉素培养基上培养过夜。 挑取单个菌 落,生长在 LB/氨苄青霉素的液体中过夜生长。制备相应的质粒, 经 NWI酶切, 凡释放 1 177bp的片段者, 为所需要的质粒, 经测 序正确后, 命名为 pSZTC 2001。 原酶基因的克隆: PSZTC2000 was digested with enzyme and treated with calf intestinal alkaline phosphatase, and the fragment was recovered. And connected with the fragment obtained in step 1.4, precipitated by adding yeast tRNA, 3M sodium acetate and absolute ethanol, rinsed with 70% ethanol, electrolyzed into E. coli, cultured on LB/ampicillin medium at 37 °C. overnight. A single colony was picked and grown overnight in a liquid of LB/ampicillin. The corresponding plasmid was prepared and digested by NWI. The fragment of 1 177 bp was released, and the desired plasmid was designated as pSZTC 2001 after being correctly sequenced. Cloning of the original enzyme gene:
据己经发表的粗糙链孢霉木糖还原酶基肉的序列, 设计下列引 物, 用于 PCR扩增该基因。According to the published sequence of the genus Streptococcus mutans xylose reductase-based meat, the following design is designed. , for PCR amplification of the gene.
F NCXRF Xbal F NCXRF Xbal
5' ggagaattctctagaaacggaagaggatttttaagatggttcctgctatcaagctcaactccR NC XRR BspEI Xmal Nhel  5' ggagaattctctagaaacggaagaggatttttaagatggttcctgctatcaagctcaactccR NC XRR BspEI Xmal Nhel
5' ggagaattctccggacccgggcattccgctagcctaaccgaaaatccagaggttctcagcg 5' ggagaattctccggacccgggcattccgctagcctaaccgaaaatccagaggttctcagcg
969bp 969bp
编号为 ATCC10333的粗糙链孢霉生长在蛋白陈 5.0克, 麦芽糖 The genus Streptomyces sp., ATCC10333, grows in protein cum 5.0 g, maltose
40.0克 /升的培养基中于 30°C过夜。 于第 2天 1 : 10稀释后, 加入 木糖至终浓度为 1%, 于 3(TC 培养 4小时后, 离心收集沉淀。 在其中加入 1毫升将 1毫升 TRIzol RNA分离试剂(购自 Invitrogen) 震荡混匀, 并经研钵研磨后, 加入 0.2亳升氯仿, 混匀, 于 25°C 放置 15分钟, 于 4°C离心 10分钟; 将上清转移到新的离心管中, 加入 0.5亳升异丙醇, 于 25°C放置 15分钟, 于 4°C离心 10分钟, 取其上清, 加入 70%的酒精漂洗 1 遍, 溶于 12μ1水中。 所有的 离心速度为 12000转 /分钟。 40.0 g / liter of the medium was incubated at 30 ° C overnight. After diluting 1:10 on day 2, xylose was added to a final concentration of 1%, and after 3 hours of TC culture, the precipitate was collected by centrifugation. 1 ml of 1 ml of TRIzol RNA isolation reagent (purchased from Invitrogen) was added thereto. After shaking and mixing, and grinding through a mortar, add 0.2 liters of chloroform, mix, place at 25 ° C for 15 minutes, centrifuge at 10 ° C for 10 minutes; transfer the supernatant to a new centrifuge tube, add 0.5 亳The isopropanol was placed at 25 ° C for 15 minutes, centrifuged at 4 ° C for 10 minutes, the supernatant was taken, rinsed with 70% alcohol for 1 time, and dissolved in 12 μl of water. All the centrifugation speed was 12,000 rpm.
立下列反应体系:  Establish the following reaction system:
自步骤 2.2的 RNA 12.0 μΐ  12.0 μΐ RNA from step 2.2
随机引物 0.5μ /μ1 3.0 μΐ  Random primer 0.5μ /μ1 3.0 μΐ
混匀后, 于 65°C孵育 5分钟, 然后缓慢冷却到 25 'C , 并放置 10分钟 然 后加入  After mixing, incubate at 65 ° C for 5 minutes, then slowly cool to 25 'C and leave for 10 minutes before adding
10 AffinityScript RT缓冲液 2.0μ1  10 AffinityScript RT Buffer 2.0μ1
dNTP 25 mM 0.8μ1  dNTP 25 mM 0.8μ1
Rnase抑制剂 40μ/μ1 Ι.ΟμΙ  Rnase inhibitor 40μ/μ1 Ι.ΟμΙ
逆转录酶 Ι.ΟμΙ  Reverse transcriptase Ι.ΟμΙ
(购自 Stratagene)  (purchased from Stratagene)
于 42 °C反应 2小时。  The reaction was carried out at 42 ° C for 2 hours.
立下列反应体系:  Establish the following reaction system:
10 Pfu DNA聚合酶缓冲液 5.0 μΐ  10 Pfu DNA Polymerase Buffer 5.0 μΐ
dNTP 2mM 5.0 μΐ  dNTP 2mM 5.0 μΐ
2.1. IF 2μΜ 5.0 μΐ  2.1. IF 2μΜ 5.0 μΐ
2.1.1R 2μΜ 5.0 μΐ  2.1.1R 2μΜ 5.0 μΐ
步骤 2.3的 cDNA 1.0 μΐ Ρίιι 2.5μ/μ1 1.0 μΐ Step 2.3 cDNA 1.0 μΐ Ρίιι 2.5μ/μ1 1.0 μΐ
dH20 28.0 μΐ dH 2 0 28.0 μΐ
反应程序: 94°C 2分钟; 然后 94°C 15秒, 50°C 15秒, 72°C 1 分钟, 循环 30次; 最后在 72°C延伸 10分钟。  Reaction procedure: 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 1 minute, cycle 30 times; finally at 72 ° C for 10 minutes.
所获得的 PCR 片段用 EcoRl 酶切, 克隆到用同样酶切处理的 pUC 19中, 经测序确证后, 命名为 pSZTC2002。  The obtained PCR fragment was digested with EcoRl, cloned into pUC 19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2002.
3.大肠杆菌磷酸木酮糖水解酶 YidA基因的克隆 3. Cloning of the E. coli phosphoxidose hydrolase YidA gene
3. 1根据已经公布的序列, 特设计下列引物用于 YidA基因的扩增: 3. 1. 1F EC YidAFXbal  3. 1 According to the published sequence, the following primers are specially designed for the amplification of the YidA gene: 3. 1. 1F EC YidAFXbal
5' ggagaattctctagaccaatctacctggggaactcatggctattaaactcattgctatcgatatgg 3. 1 . 1R EC YidAR BspEIXmalNhel  5' ggagaattctctagaccaatctacctggggaactcatggctattaaactcattgctatcgatatgg 3. 1 . 1R EC YidAR BspEIXmalNhel
gaattctccggacccgggcattccgctagcttaattcagcacatacttctcaatagcaaacg (扩增 产物 813bp )  Gaattctccggacccgggcattccgctagcttaattcagcacatacttctcaatagcaaacg (amplification product 813bp)
3.2根据步骤 1.2制备大肠杆菌染色体 DNA,并使其终浓度为 10纳克 3.2 Prepare E. coli chromosomal DNA according to step 1.2 and make it to a final concentration of 10 ng
/微升。 / Microliter.
3.3建立下列反应体系: 3.3 Establish the following reaction system:
10 Pfti缓冲液 5.0 μΐ  10 Pfti buffer 5.0 μΐ
dNTP 2mM 5.0 μΐ  dNTP 2mM 5.0 μΐ
3.1.1Ρ 2μΜ 5.0 μΐ  3.1.1Ρ 2μΜ 5.0 μΐ
3· 1.1Ι 2μΜ 5.0 μΐ  3· 1.1Ι 2μΜ 5.0 μΐ
大肠杆菌染色体 DNA 10纳克 /微升 5.0 μΐ  E. coli chromosome DNA 10 ng / microliter 5.0 μΐ
无菌水 24.5 μΐ  Sterile water 24.5 μΐ
Pfu (2.5 μ/μΐ) 5.0 μΐ  Pfu (2.5 μ/μΐ) 5.0 μΐ
反应程序: 94 °C 2分钟; 然后 94°C 15秒, 50 °C 15秒, 72 °C 1 分钟, 循环 30次; 最后在 72 °C延伸 10分钟。  Reaction procedure: 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 1 minute, cycle 30 times; finally at 72 ° C for 10 minutes.
所获得的 PCR 片段用 EcoM 酶切, 克隆到用同样酶切处理的 pUC 19中, 经测序确证后, 命名为 pSZTC2003。  The obtained PCR fragment was digested with EcoM, cloned into pUC 19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2003.
4.大肠杆菌木糖异构酶基因的克隆: 4. Cloning of the E. coli xylose isomerase gene:
4. 1根据已经公布的序列, 特设计下列引物用于基因的扩增: 4. 1. IF EC XIF Xbal 4. 1 According to the published sequence, the following primers are specially designed for gene amplification: 4. 1. IF EC XIF Xbal
5 ' ggagaattctctagaacctgattatggagttcaatatgcaagcctattttgaccagctc  5 ' ggagaattctctagaacctgattatggagttcaatatgcaagcctattttgaccagctc
4. 1. 1R EC XIR BspEI Xmal Nhel 4. 1. 1R EC XIR BspEI Xmal Nhel
5' gaagaattctccggacccgggcattccgctagcttatttgtcgaacagataatggtttaccagattt 5' gaagaattctccggacccgggcattccgctagcttatttgtcgaacagataatggtttaccagattt
(扩增产物 1323 bp ) (amplification product 1323 bp)
4.2根据步骤 1.2制备大肠杆菌染色体 DNA,并使其终浓度为 10纳克4.2 Prepare E. coli chromosomal DNA according to step 1.2 and make it to a final concentration of 10 ng
/微升。 / Microliter.
4. 3建立下列反应体系:  4. 3 Establish the following reaction system:
lO x Pfo缓冲液 5.0 μΐ  lO x Pfo buffer 5.0 μΐ
dNTP 2mM 5.0 μΐ  dNTP 2mM 5.0 μΐ
4.1. IF 2μΜ 5.0 μΐ  4.1. IF 2μΜ 5.0 μΐ
4.1.1Ι 2μΜ 5.0 μΐ  4.1.1Ι 2μΜ 5.0 μΐ
大肠杆菌染色体 DNA 10纳克 /微升 5.0 μΐ  E. coli chromosome DNA 10 ng / microliter 5.0 μΐ
无菌水 24.5 μΐ  Sterile water 24.5 μΐ
Pfu (2. 5 μ/μΐ) 5.0 μΐ  Pfu (2. 5 μ/μΐ) 5.0 μΐ
反应程序: 94°C 2分钟; 然后 94°C 15秒, 50°C 15秒, 72°C 1 分 30秒, 循环 30次; 最后在 70°C延伸 10分钟。  Reaction procedure: 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 1 minute and 30 seconds, cycle 30 times; finally at 70 ° C for 10 minutes.
所获得的 PCR 片段用 EcoRl 酶切, 克隆到用同样酶切处理的 pUC19中, 经测序确证后, 命名为 pSZTC2004。  The obtained PCR fragment was digested with EcoR1, cloned into pUC19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2004.
5.大肠杆菌 NADH/NADPH转氢酶基因的克隆: 5. Cloning of the NADH/NADPH transhydrogenase gene from Escherichia coli:
5. 1根据己经公布的序列, 特设计下列引物用于 NADH/NADPH转氢 酶基因的扩增:  5. 1 Based on the published sequence, the following primers were specifically designed for the amplification of the NADH/NADPH transhydrogenase gene:
5. l . IF EC TRAF Xbal 5. l . IF EC TRAF Xbal
5' ggactgcagtctagaccggcggcgaaggcgctgcaatgggcctggttaagcaagg  5' ggactgcagtctagaccggcggcgaaggcgctgcaatgggcctggttaagcaagg
5. 1. 1R EC TRAR BspEI Xmal Nhel 5. 1. 1R EC TRAR BspEI Xmal Nhel
5' gaactgcagtccggacccgggcattccgctagcttaaaacaggcggtttaaaccgtttaac (扩增 产物 1335 bp )  5' gaactgcagtccggacccgggcattccgctagcttaaaacaggcggtttaaaccgtttaac (amplification product 1335 bp)
5.2根据步骤 1.2制备大肠杆菌染色体 DNA,并使其终浓度为 10纳克 5.2 Prepare E. coli chromosomal DNA according to step 1.2 and make it to a final concentration of 10 ng
/微升。 5.3建立下列反应体系: / Microliter. 5.3 Establish the following reaction system:
lO x Pfu缓冲液 5.0 μΐ  lO x Pfu buffer 5.0 μΐ
dNTP 2mM 5.0 μΐ  dNTP 2mM 5.0 μΐ
5. 1. ΙΡ 2μΜ 5.0 μΐ  5. 1. ΙΡ 2μΜ 5.0 μΐ
5. 1. 1Κ 2μΜ 5.0 μΐ  5. 1. 1Κ 2μΜ 5.0 μΐ
大肠杆菌染色体 DNA 10纳克 /微升 5.0 μΐ  E. coli chromosome DNA 10 ng / microliter 5.0 μΐ
无菌水 24.5 μΐ  Sterile water 24.5 μΐ
Pfu (2.5 μ/μΐ) 5.0 μΐ  Pfu (2.5 μ/μΐ) 5.0 μΐ
反应程序: 94 °C 2分钟; 然后 94°C 15秒, 50Γ 15秒, 72°C 1 分 30秒, 循环 30次; 最后在 72°C延伸 10分钟。  Reaction procedure: 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 Γ 15 seconds, 72 ° C for 1 minute 30 seconds, cycle 30 times; finally at 72 ° C for 10 minutes.
所获得的 PCR片段用 Pst\酶切,克隆到用同样酶切处理的 pUC 19 中, 经测序确证后, 命名为 pSZTC2005。  The obtained PCR fragment was digested with Pst\, cloned into pUC 19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2005.
6.谷氨酸棒状杆菌木酮糖表位酶基因的克隆: 6. Cloning of the xylulose epitope enzyme gene of Corynebacterium glutamicum:
6. 1.根据已经公布的序列, 特设计下列引物用于谷氨酸棒状杆菌木酮 糖表位酶基因的扩增:  6. 1. According to the published sequence, the following primers were specially designed for the amplification of the xylosidase gene of Corynebacterium glutamicum:
6. l . IF CGEPIF Xbal 6. l . IF CGEPIF Xbal
ggagaattctctagaagagggctatgatttagggcatggcacaacgtactccactaatc Ggagaattctctagaagagggctatgatttagggcatggcacaacgtactccactaatc
6. 1. 1R CGEPI BspEI Xmal Nhel 6. 1. 1R CGEPI BspEI Xmal Nhel
5' ggagaattctccggacccgggcattccgctagcttactgcgcgagtgctcg (扩增产物 660bp )  5' ggagaattctccggacccgggcattccgctagcttactgcgcgagtgctcg (amplification product 660bp)
6. 2建立下列反应体系:  6. 2 Establish the following reaction system:
Figure imgf000013_0001
Figure imgf000013_0001
反应程序: 94°C 2分钟; 然后 94°C 15秒, 50°C 15秒, 72 °C 1 分钟, 循环 30次; 最后在 72°C延伸 10分钟。  Reaction procedure: 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 1 minute, cycle 30 times; finally at 72 ° C for 10 minutes.
所获得的 PCR 片段用 EcoRl 酶切, 克隆到用同样酶切处理的 pUC19中, 经测序确证后, 命名为 pSZTC2006。 The obtained PCR fragment was digested with EcoRl and cloned into the same digestion treatment. In pUC19, after sequencing confirmation, it was named pSZTC2006.
7.谷氨酸棒状杆菌乳酸脱氢酶促进子的克隆: 7. Cloning of the lactic acid dehydrogenase promoter of Corynebacterium glutamicum:
7. 1根据已经公布的序列, 特设计下列引物, 用以乳酸脱氢酶促进子 序列的扩增:  7. 1 Based on the published sequence, the following primers were specifically designed to amplify the lactate dehydrogenase promoter sequence:
7. l . IF CGLDHPF Xbal 7. l . IF CGLDHPF Xbal
5 ' ggagaattctctagacggaactagctctgcaatgacctg  5 ' ggagaattctctagacggaactagctctgcaatgacctg
7. 1. 1R CGLDHPR BspEI Xmal Nhel  7. 1. 1R CGLDHPR BspEI Xmal Nhel
5' ggagaattctccggacccgggcattccgctagccgatcccacttcctgatttccctaa (扩增 产物 348bp )  5' ggagaattctccggacccgggcattccgctagccgatcccacttcctgatttccctaa (amplification product 348bp)
7.2建立下列反应体系:  7.2 Establish the following reaction system:
lO x Pfo缓冲液 5.0 μΐ  lO x Pfo buffer 5.0 μΐ
dNTP 2mM 5.0 μΐ  dNTP 2mM 5.0 μΐ
7. 1. ΙΡ 2μΜ 5.0 μΐ  7. 1. ΙΡ 2μΜ 5.0 μΐ
7. 1. 1ί12μΜ 5.0 μΐ  7. 1. 1ί12μΜ 5.0 μΐ
谷氨酸棒状杆菌染色体 DNA 10纳克 /微升 5.0 μΐ  Corynebacterium glutamicum chromosome DNA 10 ng / microliter 5.0 μΐ
无菌水 24.5 μΐ  Sterile water 24.5 μΐ
Piu(2.5 μ/μΐ) 0.5μ1  Piu (2.5 μ/μΐ) 0.5μ1
反应程序: 94°C 2分钟; 然后 94°C 15秒, 50°C 15秒, 72°C 30 秒, 循环 30次; 最后在 72°C延伸 10分钟。  Reaction procedure: 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 50 ° C for 15 seconds, 72 ° C for 30 seconds, cycle 30 times; finally at 72 ° C for 10 minutes.
所获得的 PCR 片段用 EcoRl 酶切, 克隆到用同样酶切处理的 pUC19中, 经测序确证后, 命名为 pSZTC2007。  The obtained PCR fragment was digested with EcoRl, cloned into pUC19 treated with the same restriction enzyme, and confirmed by sequencing, and designated as pSZTC2007.
8.氯霉素抗性基因的克隆: 8. Cloning of the chloramphenicol resistance gene:
8. 1根据己经公布的 pACYC184的序列, 特设计下列引物, 用以氯霉 素抗性基因的扩增:  8. 1 Based on the published sequence of pACYC184, the following primers were designed to amplify the chloramphenicol resistance gene:
8. l . IF CATF Xbal 8. l . IF CATF Xbal
5' ggactgcagtctagacaggagctaaggaagctaaaatggagaaaaaaatcactggatataccacc 5' ggactgcagtctagacaggagctaaggaagctaaaatggagaaaaaaatcactggatataccacc
8. 1. 1R CATR BspEI Xmal Nhel 8. 1. 1R CATR BspEI Xmal Nhel
5' ggactgcagtccggacccgggcattccgctagctccggacccgggcattccgctagcttacgcccc gccctg ccac (扩增产物 660bp ) 8.2建立下列反应体系: 5' ggactgcagtccggacccgggcattccgctagctccggacccgggcattccgctagcttacgcccc gccctg ccac (amplification product 660bp) 8.2 Establish the following reaction system:
lO x Pfo缓冲液 5.0 μΐ  lO x Pfo buffer 5.0 μΐ
dNTP 2mM 5.0 μΐ  dNTP 2mM 5.0 μΐ
8. 1. ΙΡ 2μΜ 5.0 μΐ  8. 1. ΙΡ 2μΜ 5.0 μΐ
8. 1. \Κ 2μΜ 5.0 μΐ  8. 1. \Κ 2μΜ 5.0 μΐ
pACYC184DNA 10纳克 /微升 5.0 μΐ  pACYC184DNA 10 ng / μl 5.0 μΐ
无菌水 24.5 μΐ  Sterile water 24.5 μΐ
Pfti(2.5 μ/μΐ) 0.5μ1  Pfti (2.5 μ/μΐ) 0.5μ1
反应程序: 94°C 2分钟; 然后 94°C 15秒, 5(TC 15秒, 72 °C 1 分钟, 循环 30次; 最后在 72°C延伸 10分钟。  Reaction procedure: 94 ° C for 2 minutes; then 94 ° C for 15 seconds, 5 (TC 15 seconds, 72 ° C for 1 minute, cycle 30 times; finally extended at 72 ° C for 10 minutes.
所获得的 PCR片段用 ftrt酶切,克隆到用同样酶切处理的 pUC19 中, 经测序确证后, 命名为 pSZTC2008。  The obtained PCR fragment was digested with ftrt, cloned into pUC19 treated with the same digestion, and confirmed by sequencing, and designated as pSZTC2008.
9.木糖还原酶、 磷酸木酮糖水解酶、 木糖异构酶、 氯霉素抗性基因、 木酮糖表位酶和 NADAH/NADPH转氢酶的顺序克隆: 9. Sequential cloning of xylose reductase, xylulose hydrolase, xylose isomerase, chloramphenicol resistance gene, xylulose epitope enzyme and NADAH/NADPH transhydrogenase:
9.1将 pSZTC2001用 N¾I和^ wl酶切,并用小牛肠道碱性磷酸酶处 理, 回收片段备用。  9.1 pSZTC2001 was digested with N3⁄4I and ^wl, and treated with calf intestinal alkaline phosphatase, and the fragment was recovered for use.
9.2 将 pSZTC2002 , pSZTC2003 , pSZTC2004 , pSZTC2005 , pSZTC2006, pSZTC2007和 pSZTC2008分别用 Xba\和 BspEl 酶切, 并从琼脂糖胶上回收 969bp, 813bp, 1323bp, 1335bp, 660bp, 348bp和 660bp的片段备用。 9.2 pSZTC2002, pSZTC2003, pSZTC2004, pSZTC2005, pSZTC2006, pSZTC2007 and pSZTC2008 were digested with Xba\ and BspEl, respectively, and 969 bp, 813 bp, 1323 bp, 1335 bp, 660 bp, 348 bp and 660 bp fragments were recovered from the agarose gel.
. 3将 9.1所获得的片段与从 pSZTC2007所获得的 348bp的片段连接, 经电转到大肠 杆菌中, 对所获得的单个质粒用 EcoRL 凡释放 1525bp片段者,为所需要的质粒,将其中之一命名为 pSZTC2009。 .4将 pSZTC2009用 Nhel和 Xmal酶切,并用小牛肠道碱性磷酸酶处 理, 回收的片段 与从 pSZTC2002所获得的 969bp的片段连接, 经电转到大肠杆菌中, 对所获得的单个质粒用 £ RI酶切, 凡释 放 2494bp 片段者, 为所需要的质粒, 将其中之一命名为 pSZTC2010。 3. The fragment obtained by 9.1 was ligated with the 348 bp fragment obtained from pSZTC2007, electroporated into E. coli, and the obtained single plasmid was subjected to EcoRL. The 1525 bp fragment was released, and one of the desired plasmids was used. Named pSZTC2009. .4 pSZTC2009 was digested with Nhel and Xmal and treated with calf intestinal alkaline phosphatase. The recovered fragment was ligated with the 969 bp fragment obtained from pSZTC2002, electroporated into E. coli, and the obtained single plasmid was used. £ RI digestion, where the 2494 bp fragment was released, one of the required plasmids was named pSZTC2010.
.5将 pSZTC2010用 Mel和^ 酶切,并用小牛肠道碱性磷酸酶处 理, 回收的片段 与从 pSZTC2003所获得的 813bp的片段连接, 经电转到大肠杆菌中, 对所获得的单个质粒用 coRI酶切, 凡释 放 3307bp 片段者, 为所需要的质粒, 将其中之一命名为 pSZTC2011。 .5 pSZTC2010 was digested with Mel and ^, and the calf intestinal alkaline phosphatase was used. The recovered fragment was ligated with the 813 bp fragment obtained from pSZTC2003, electroporated into E. coli, and the obtained single plasmid was digested with coRI, and the 3307 bp fragment was released, and the desired plasmid was used. Named pSZTC2011.
pSZTC201 1用 N½I和 wwl酶切,并用小牛肠道碱性磷酸酶处 理, 回收的片段 与从 pSZTC2004所获得的 1323bp的片段连接, 经电转到大肠杆菌中, 对所获得的单个质粒用 EcoRl , 凡释放 4630bp 片段者, 为所需要的质粒, 将其中之一命名为 pSZTC2012。  pSZTC201 1 was digested with N1⁄2I and wwl and treated with calf intestinal alkaline phosphatase. The recovered fragment was ligated with the 1323 bp fragment obtained from pSZTC2004, electroporated into E. coli, and the obtained single plasmid was treated with EcoRl. For those who released the 4630 bp fragment, one of the required plasmids was named pSZTC2012.
将 pSZTC2012用 Nhel和 Xmal酶切, 并用小牛肠道碱性磷酸酶 处理,回收的片段 与从 pSZTC2008所获得的 660bp的片段连接, 经电转到大肠杆菌中, 对所获得的单个 质粒用 EcoRl, 凡释放 991bp和 4109bp片段者, 为所需要的质粒, 将其中之一命名为 pSZTC2013。 pSZTC2012 was digested with Nhel and Xmal, and treated with calf intestinal alkaline phosphatase. The recovered fragment was ligated with the 660 bp fragment obtained from pSZTC2008, electroporated into E. coli, and EcoRl was used for the obtained single plasmid. For those who released the 991 bp and 4109 bp fragments, one of the required plasmids was named pSZTC2013.
将 pSZTC2013用 Nhe\和 Xm d酶切, 并用小牛肠道碱性磷酸酶 处理, 回收的片段与从 pSZTC2006所获得的 660bp的片段连接, 经电转到大肠杆菌中, 对所获得的单个质粒用 EcoRl 凡释放 1651bp和 4109bp片段者, 为所需要的质粒, 将其中之一命名为 pSZTC2014。 pSZTC2013 was digested with Nhe\ and Xm d and treated with calf intestinal alkaline phosphatase. The recovered fragment was ligated with the 660 bp fragment obtained from pSZTC2006, electroporated into E. coli, and the obtained single plasmid was used. EcoRl For the release of the 1651 bp and 4109 bp fragments, one of the required plasmids was named pSZTC2014.
pSZTC2014用 Nhel和 Xmai酶切,并用小牛肠道碱性磷酸酶处 理, 回收的片段与从 pSZTC2005所获得的 1335bp的片段连接, 经电转到大肠杆菌中, 对所获得的单个质粒用 JScoRl 凡释放 1143bp, 1843bp和 4109bp片段者, 为所需要的质粒, 将其中之 一命名为 pSZTC2015。  pSZTC2014 was digested with Nhel and Xmai and treated with calf intestinal alkaline phosphatase. The recovered fragment was ligated with the 1335 bp fragment obtained from pSZTC2005, electroporated into E. coli, and the obtained single plasmid was released with JScoRl. For the 1143 bp, 1843 bp and 4109 bp fragments, one of the required plasmids was named pSZTC2015.
产木糖醇的谷氨酸棒状杆菌的构建和木糖醇的生产  Construction of xylitol-producing Corynebacterium glutamicum and production of xylitol
将 pBSZTC2015用 Nort酶切, 回收 7095bp的片段,使其片段量 为 5微克。 然后用 T4 DNA连接酶连接, 加入酵母 tRNA、 3M 醋酸钠和无水乙醇回收沉淀,经 70°/。的乙醇漂洗 2遍后,在 2500 伏的电压下,电转到谷氨酸棒状杆菌中,然后再生长在含有 10微 克 /亳升氯霉素的 LB/琼脂培养基上。 所获得的耐氯霉素的菌落, 用 2. 1. IF和 2. 1. 1R, 5. 1. IF和 5. 1. 1R二对引物鉴定, 凡获得 969bp和 1335bp片段者, 为阳性菌株, 共获得阳性菌株 20株, 挑取其中 3株, 分别命名为 BSZTC2000-2。 The pBSZTC2015 was digested with Nort, and a 7095 bp fragment was recovered to have a fragment amount of 5 μg. Then connect with T4 DNA ligase, add yeast tRNA, 3M The precipitate was recovered from sodium acetate and absolute ethanol at 70 ° /. The ethanol was rinsed twice and then electrolyzed to Corynebacterium glutamicum at 2500 volts and then regenerated on LB/agar medium containing 10 μg/liter chloramphenicol. The obtained chloramphenicol-resistant colonies were identified by using 1. 1. IF and 2. 1. 1R, 5. 1. IF and 5. 1. 1R two pairs of primers, and those having 969 bp and 1335 bp fragments were positive strains. A total of 20 positive strains were obtained, and 3 of them were picked and named as BSZTC2000-2.
10.2将 BSZTC2000-2002于 LB/氯霉素的培养基中过夜生长, 收集沉 淀, 经 0.1M的磷酸缓冲液漂洗后, 将海藻酸钠溶液与细菌混合 均匀, 使海藻酸钠最终浓度为 2%, 含菌量约为 109pfb/ml; 将海 藻酸钠与菌体混合液用针形管滴入 5%的 CaCl2溶液中, 固定化 8h; 滤出颗粒, 用生理盐水洗净, 备用。 10.2 BSZTC2000-2002 was grown overnight in LB/chloramphenicol medium, and the precipitate was collected. After rinsing with 0.1M phosphate buffer, the sodium alginate solution was mixed with the bacteria to make the final concentration of sodium alginate 2%. The bacterial content is about 10 9 pfb/ml; the sodium alginate and the bacterial mixture are dropped into a 5% CaCl 2 solution by a needle tube, and fixed for 8 hours; the particles are filtered out, washed with physiological saline, and used. .
10.3将步骤 10.2所得的颗粒装入固定化柱中, 并在蠕动泵的作用下, 按照每分钟 0.1体积柱容从柱底加入 0.5M葡萄糖, 使从柱顶流 出的反应液循环, 确保能够与固定化柱中的细菌反应 2小时。 然 后收集反应液, 经流化床分离, 结晶, 可制得木糖醇。 经高压液 相分析, 葡萄糖的转化率分别为 66.8, 68.3%和 70%。 序列表说明: 序列表中 SEQ ID N0.1和 2分别为 1. l. IF XylUp和 1. 1. IR XylDn的核苷酸 序列; SEQ ID N0.3和 4分别为 1. 1.2FXylUp 1和 1. 1.2R XylDnl的核苷酸序列; SEQ ID N0.5和 6分别为 1.5. IF BamHINotlEcoRI和 1.5. IR BamHINotlEcoRI的 核苷酸序列; SEQ ID NO.7和 8分别为 2. 1. IF NCXRFXbal和 2. 1. IR NC XRR BspEI Xmal Nhel 的核苷酸序列; SEQ ID NO.9 和 10 分别为 3. 1. IF EC YidAFXbal和 3.1. IR EC YidAR BspEIXmalNhel的核苷酸序列; SEQ ID NO.11 和 12分别为 4. 1. IF EC XIFXbal和 4. 1. IR EC XIR BspEIXmalNhel的核苷酸序 列; SEQ ID N0.13和 14分别为 5. 1. IF EC TRAFXbal和 5. 1. IR EC TRAR BspEIXmalNhel 的核苷酸序列; SEQ ID NO.15和 16分别为 6. 1. IF CGEPlFXbal 和 6.1.1 RCGEPIBspEIXmalNhel的核苷酸序列; SEQ ID NO.17和 18分别为 7. 1. IF CGLDHPF Xbal和 7. 1. IR CGLDHPR BspEIXmalNhel的核苷酸序列; SEQ ID NO.19和 20分别为 8. 1. IF CATFXbal和 8. 1. IR CATR BspEIXmalNhel的核苷酸 序列。 工业实用性 本发明提供了一种糖醇的制备方法, 利用同源重组方法, 将一种 糖还原酶及其相应的糖异构酶、 磷酸糖水解酶、 糖表位酶和转氢酶的 编码基因整合到宿主的染色体上,在这一整合过程中使宿主的相应糖 激酶失活,使所获得的转化子能够利用基因重组提供的糖代谢通路将 相应的糖转化成为相应的糖醇。在转化谷氨酸棒状杆菌生产木糖醇的 实验中, 本发明方法将葡萄糖转化为木糖醇的转化率可达 70%以上, 说明本发明方法有望用于大规模的工业生产。 10.3. The granules obtained in step 10.2 were placed in an immobilization column, and 0.5 M glucose was added from the bottom of the column according to a volume of 0.1 volume per minute under the action of a peristaltic pump to circulate the reaction liquid flowing from the top of the column to ensure The bacteria in the immobilized column were reacted for 2 hours. The reaction solution is then collected, separated by a fluidized bed, and crystallized to obtain xylitol. After high pressure liquid phase analysis, the conversion rates of glucose were 66.8, 68.3% and 70%, respectively. BRIEF DESCRIPTION OF THE SEQUENCE LISTING: SEQ ID N0.1 and 2 in the sequence listing are 1. l. IF XylUp and 1. 1. IR XylDn nucleotide sequence; SEQ ID N0.3 and 4 are 1. 1.2FXylUp 1 and 1. IF NCXRFXbal SEQ ID NO. 7 and 8 are respectively 1. 1. IF NCXRFXbal SEQ ID NO. 7 and 8 are respectively 1.5. IF BamHINotlEcoRI and 1.5. IR BamHINotlEcoRI nucleotide sequence; SEQ ID NO. And 2. 1. IR NC XRR BspEI Xmal Nhel nucleotide sequence; SEQ ID NO. 9 and 10 are respectively 3. 1. IF EC YidAFXbal and 3.1. IR EC YidAR BspEIXmalNhel nucleotide sequence; SEQ ID NO. 11 and 12 are respectively 4. 1. IF EC XIFXbal and 4. 1. IR EC XIR BspEIXmalNhel nucleotide sequence; SEQ ID N0.13 and 14 are respectively 5. 1. IF EC TRAFXbal and 5. 1. IR EC Nucleotide sequence of TRAR BspEIXmalNhel; SEQ ID NO. 15 and 16 are respectively 6. 1. IF CGEP1FXbal and 6.1.1 RCGEPIBspEIXmalNhel nucleotide sequence; SEQ ID NO. 17 and 18 are respectively 7. 1. IF CGLDHPF Xbal And 1. 1. IR CGLDHPR BspEIXmalNhel nucleotide sequence; SEQ ID NO. 19 and 20 are 8. 1. IF CATFXbal and 8. 1. IR CATR BspEIXmalNhel nucleotide sequence. Industrial applicability The invention provides a method for preparing a sugar alcohol, which utilizes a homologous recombination method to integrate a sugar reductase and its corresponding glycogen isomerase, phosphoglucose hydrolase, glycosylase and transhydrogenase encoding genes. On the chromosome of the host, the corresponding glycokinase of the host is inactivated during this integration process, so that the obtained transformant can convert the corresponding sugar into the corresponding sugar alcohol by utilizing the sugar metabolic pathway provided by genetic recombination. In the experiment for converting xylitol from Corynebacterium glutamicum, the conversion rate of glucose to xylitol by the method of the present invention can reach 70% or more, indicating that the method of the present invention is expected to be used for large-scale industrial production.

Claims

权利要求书 Claim
1、 一种基因工程菌, 其通过如下方法制备获得: 利用同源重组 方法, 将一种糖还原酶及其相应的糖异构酶、 磷酸糖水解酶、 糖表位 酶和转氢酶的编码基因整合到宿主的染色体上,在这一整合过程中使 宿主的相应糖激酶失活,使所获得的转化子能够利用基因重组提供的 糖代谢通路将相应的糖转化成为相应的糖醇。  A genetically engineered strain obtained by the following method: using a homologous recombination method, a sugar reductase and its corresponding sugar isomerase, phosphoglucose hydrolase, glycoside enzyme and transhydrogenase The coding gene is integrated into the chromosome of the host, and the corresponding glycokinase of the host is inactivated during this integration process, so that the obtained transformant can convert the corresponding sugar into the corresponding sugar alcohol by using the sugar metabolic pathway provided by genetic recombination.
2、 如权利要求 1所述的基因工程菌, 其通过如下方法制备获得: 将糖激酶基因的两侧序列以及相应的糖还原酶基因、 糖异构酶基因、 磷酸糖水解酶基因、 糖表位酶基因和转氢酶基因相连接、 糖激酶基因 的两侧序列分别位于 5,和 3,端,通过同源重组,整合到宿主糖激酶基 因所在的位置, 并使该基因失活。  2. The genetically engineered bacteria according to claim 1, which is obtained by the following method: a flanking sequence of a glycokinase gene and a corresponding sugar reductase gene, a sugar isomerase gene, a phosphohydrolase gene, a glycoform The enzyme gene and the transhydrogenase gene are ligated, and the flanking gene is flanked at the 5th and 3rd ends, respectively, and integrated into the position of the host glycokinase gene by homologous recombination, and the gene is inactivated.
3、 如权利要求 1所述的基因工程菌, 其中所述的糖还原酶为木 糖还原酶、所述的糖异构酶为木糖异构酶、所述的糖水解酶为磷酸木 酮糖水解酶、 所述的糖表位酶为磷酸木酮糖表位酶。  3. The genetically engineered bacteria according to claim 1, wherein the sugar reductase is xylose reductase, the sugar isomerase is xylose isomerase, and the sugar hydrolase is xylone The glycohydrolase, the glycotopic enzyme is a xylulose epitope enzyme.
4、 如权利要求 3所述的基因工程菌, 其特征在于, 所述木糖还 原酶来自粗糙链孢霉。  The genetically engineered bacterium according to claim 3, wherein the xylose reductase is derived from Neurospora crassa.
5、 如权利要求 3所述的基因工程菌, 其特征在于, 所述木糖异 构酶来自大肠杆菌。  The genetically engineered bacterium according to claim 3, wherein the xylose isomerase is derived from Escherichia coli.
6、 如权利要求 3所述的基因工程菌, 其特征在于, 所述磷酸木 酮糖水解酶来自大肠杆菌。  The genetically engineered bacterium according to claim 3, wherein the phosphoxyl ketose hydrolase is derived from Escherichia coli.
7、 如权利要求 3所述的基因工程菌, 其特征在于, 所述转氢酶 来自大肠杆菌。  The genetically engineered bacteria according to claim 3, wherein the transhydrogenase is derived from Escherichia coli.
8、 如权利要求 3所述的基因工程菌, 其特征在于, 所述磷酸木 酮糖表位酶来自谷氨酸棒状杆菌。  The genetically engineered bacterium according to claim 3, wherein the phosphoxyl ketose epitope enzyme is derived from Corynebacterium glutamicum.
9、 如权利要求 3〜8所述的基因工程菌, 其特征在于, 所述的宿 主为谷氨酸棒状杆菌。  The genetically engineered bacteria according to any one of claims 3 to 8, wherein the host is Corynebacterium glutamicum.
10、 如权利要求 9所述的基因工程菌, 其特征在于, 重组序列的 促进子为谷氨酸棒状杆菌木酮糖激酶的促进子,或者为谷氨酸棒状杆 菌乳酸脱氢酶的促进子。 The genetically engineered bacteria according to claim 9, wherein the recombinant sequence is The promoter is a promoter of Corynebacterium glutamicum xylulose kinase, or a promoter of L. glutamicum lactate dehydrogenase.
11、权利要求 1~10任一项所述基因工程菌在制备糖醇中的应用。 11. Use of the genetically engineered bacteria according to any one of claims 1 to 10 for the preparation of a sugar alcohol.
12、 一种糖醇的制备方法, 其包括利用杈利要求 1~10所述的基 因工程菌将糖转化为糖醇。 12. A process for the preparation of a sugar alcohol which comprises converting a sugar into a sugar alcohol using a genetically engineered bacteria as described in claims 1 to 10.
13、 如权利要求 12所述的方法, 其特征在于, 釆用固定化发酵 方法生产糖醇。  13. The method of claim 12, wherein the sugar alcohol is produced by an immobilized fermentation process.
PCT/CN2008/001312 2007-07-13 2008-07-14 A preparation method of sugar alcohol WO2009009956A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA2007101306584A CN101092619A (en) 2007-07-13 2007-07-13 Method for preparing sugar alcohol
CN200710130658.4 2007-07-13

Publications (1)

Publication Number Publication Date
WO2009009956A1 true WO2009009956A1 (en) 2009-01-22

Family

ID=38991060

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2008/001312 WO2009009956A1 (en) 2007-07-13 2008-07-14 A preparation method of sugar alcohol

Country Status (2)

Country Link
CN (1) CN101092619A (en)
WO (1) WO2009009956A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101092619A (en) * 2007-07-13 2007-12-26 北京神洲天才科技发展有限公司 Method for preparing sugar alcohol

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1395618A (en) * 2000-01-21 2003-02-05 达尼斯科甜味剂股份有限公司 Production of five-carbon sugars and sugar alcohols
US20030068791A1 (en) * 1992-11-05 2003-04-10 Xyrofin Oy Manufacture of five-carbon sugars and sugar alcohols
WO2005113759A2 (en) * 2004-05-19 2005-12-01 Biotechnology Research And Development Corporation Microbial production of xylitol via a hexose phosphate and a pentose phosphate intermediate
CN101092619A (en) * 2007-07-13 2007-12-26 北京神洲天才科技发展有限公司 Method for preparing sugar alcohol

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068791A1 (en) * 1992-11-05 2003-04-10 Xyrofin Oy Manufacture of five-carbon sugars and sugar alcohols
CN1395618A (en) * 2000-01-21 2003-02-05 达尼斯科甜味剂股份有限公司 Production of five-carbon sugars and sugar alcohols
WO2005113759A2 (en) * 2004-05-19 2005-12-01 Biotechnology Research And Development Corporation Microbial production of xylitol via a hexose phosphate and a pentose phosphate intermediate
CN101092619A (en) * 2007-07-13 2007-12-26 北京神洲天才科技发展有限公司 Method for preparing sugar alcohol

Also Published As

Publication number Publication date
CN101092619A (en) 2007-12-26

Similar Documents

Publication Publication Date Title
EP2100967B1 (en) Method for producing lacto-n-biose i or galacto-n-biose
US20180162895A1 (en) Method for preparing nicotinamide mononucleotide (nmn)
KR20210010472A (en) Use of glycosidase in the production of oligosaccharides
CN105624077B (en) Sequential enzyme surface co-display system and application thereof
EP3561049A1 (en) Genetically engineered bacterium of coexpressing cyclohexanone monooxygenase and isopropanol dehydrogenase and use thereof
WO2021184883A1 (en) Method for preparing l-glufosinate-ammonium by deracemization using bio-enzyme, mutant of glufosinate-ammonium dehydrogenase, and application thereof
CN113528480B (en) Alpha-1, 2-fucosyltransferase mutant and construction method and application thereof
CN106414728A (en) Agarooligosaccharide hydrolase and method for producing 3,6-anhydro-l-galactose and galactose from agarose by using same
US20130337541A1 (en) Thermostable chitosanase
CN107603994A (en) A kind of κ carrageenases and its gene and application
CN109234299B (en) Method for expressing and preparing lactobiose phosphorylase
US11268114B2 (en) Method for producing anhydrous galactose derived from seaweed
US10883128B2 (en) Method of producing gentiobiose or glucose from β-glucan using β-1,6-endoglucanase
CN106520733B (en) Beta-xylosidase enzyme aggregate and preparation method thereof
WO2009009956A1 (en) A preparation method of sugar alcohol
CN116676296A (en) Beta-1, 3-glucanase mutants with improved enzymatic activity
KR102320074B1 (en) Method of producing a recombinant microorganism
EP2094840B1 (en) Novel n-acetylglucosamine-2-epimerase and method for producing cmp-neuraminic acid using the same
CN116200353A (en) Carbonyl reductase mutant, recombinant bacterium and application thereof
KR101877120B1 (en) Process for preparing 2'-Deoxycytidine using bioconversion
US8137946B2 (en) Recombinant GRAS strains expressing thermophilic arabinose isomerase as an active form and method of preparing food grade tagatose by using the same
CN113755466A (en) Fructose-bisphosphatase mutants and their use in carbohydrate synthesis
CN116083382B (en) Probiotic engineering bacteria for expressing lactic acid oxidase, expression product and application thereof
CN112481245B (en) Recombinant D-tagatose 3 epimerase DTE-CM and construction method and application thereof
KR101274976B1 (en) An alpha-Xylosidase mutants modified at their proton-donor/acceptor catalyst and high efficiency transglycosylation with the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08783517

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08783517

Country of ref document: EP

Kind code of ref document: A1